EGFR and neoplasm: One possible explanation is that the intratumoral heterogeneity of EGFR T790M mutation in tumor tissues results in sampling bias during the tumor biopsy procedures, which contributes to underestimating the incidence of this mutation and leads to the lack of statistical differences found in the present study.